Extra year of chemotherapy lowers the risk of cancer recurrence in children with Ikaros leukemia

Extra year of chemotherapy lowers the risk of cancer recurrence in children with Ikaros leukemia

Many children with ALL have a good outcome from their disease. After two years of chemotherapy treatment, nine out of ten children are cured. But some children have a more aggressive form of the disease. For example, children with the so-called Ikaros change in the DNA of their leukemia cells have a higher risk of … Read more